| 國立成功大學 |
2023 |
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized
|
Chiu, Y.-F.;Liu, T.-W.;Shan, Y.-S.;Chen, J.-S.;Li, C.-P.;Ho, C.-L.;Hsieh, R.-K.;Hwang, T.-L.;Chen, L.-T.;Ch'ang, H.-J. |
| 國立成功大學 |
2023 |
Charge Carrier Dynamics of CsPbBr3/g-C3N4Nanoheterostructures in Visible-Light-Driven CO2-to-CO Conversion
|
Chen, Y.-H.;Tsai, K.-A.;Liu, T.-W.;Chang, Y.-J.;Wei, Y.-C.;Zheng, M.-W.;Liu, S.-H.;Liao, M.-Y.;Sie, P.-Y.;Lin, J.-H.;Tseng, S.-W.;Pu, Y.-C. |
| 臺大學術典藏 |
2022-09-15T09:48:02Z |
Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps
|
Liao C.-T.; Wen Y.-W.; Lee S.-R.; Ng S.-H.; Liu T.-W.; Tsai S.-T.; Tsai M.-H.; Lin J.-C.; Chien C.-Y.; PEI-JEN LOU; Wang C.-P.; Chu P.-Y.; Leu Y.-S.; Tsai K.-Y.; Terng S.-D.; Chen T.-M.; Wang C.-H.; Chen W.-C.; Lee L.-Y.; Lin C.-Y.; Wang H.-M.; Fang T.-J.; Huang S.-F.; Kang C.-J.; Chang K.-P.; Yen T.-C.; Yang L.-Y.; Lin C.-H.; for the Taiwan Oral Cavity Cancer Advisory Group |
| 臺大學術典藏 |
2022-09-06T07:43:27Z |
Role for α-L-fucosidase in the control of Helicobacter pylori-infected gastric cancer cells
|
Liu T.-W.; Ho C.-W.; Huang H.-H.; Chang S.-M.; Popat S.D.; Wang Y.-T.; MING-SHIANG WU; Chen Y.-J.; Lin C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:12Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.; Cheng A.-L.; CHIUN HSU; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:21:12Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; CHIUN HSU; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:21:08Z |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Cheng A.-L.; Chen P.-J.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; Li C.-C.; Liao Y.-M.; Chang M.-C.; Young J.-H.; Hsiao H.-H.; Lin T.-H.; Lin S.-F.; Wang M.-C.; Hwang W.-S.; Su I.-J.; CHIUN HSU; Hsiung C.A. |
| 臺大學術典藏 |
2022-08-19T00:20:50Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Cheng A.-L.; Chen P.-J.; Liu T.-W.; Chang C.-S.; Tien H.-F.; CHIUN HSU; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J. |
| 臺大學術典藏 |
2022-08-19T00:20:45Z |
A decade of changes in preferences for life-sustaining treatments among terminally ill patients with cancer
|
Chiang M.-C.; Liu L.N.; Sung Y.-C.; Hsieh C.-I.; Chang S.-Y.; Chang Y.-H.; Chang C.-S.; CHIUN HSU; Wen F.-H.; Liu T.-W.; Tang S.T. |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
CHIUN HSU; Taiwan Cooperative Oncology Group; Liu T.-W.; Chen P.-J.; Cheng A.-L.; Lin J.; Yuan Q.; Xia N.; Yao M.; Lin S.-J.; Chen J.-H.; Chang C.-S.; Pei S.-N.; Tsou H.-H.; Yang H.-C. |
